Picture of Quanterix logo

QTRX — Quanterix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapValue Trap

Quanterix Corp reports results for the quarter ended in December - Earnings Summary

* Quanterix Corp  QTRX.OQ  reported a quarterly adjusted
loss
of 33 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -50 cents.  The mean expectation of
five analysts for the quarter was for a loss of 32 cents per
share. Wall Street expected results to range from -38 cents
to -28 cents per share.
    * Revenue rose 22.2% to $31.55 million from a year ago;
analysts
expected $29.84 million. 
    * Quanterix Corp's reported EPS for the quarter was a loss
of 33
cents​.
    * The company reported a quarterly loss of $12.41 million.
    * Quanterix Corp shares had fallen by 14.1% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 8.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Quanterix
Corp is
$32.00 

This summary was machine generated from LSEG data February 29 at
09:39 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.32          -0.33          Missed
 Sep. 30 2023      -0.37          -0.21          Beat
 Jun. 30 2023      -0.38          -0.16          Beat
 Mar. 31 2023      -0.38          -0.16          Beat

Recent news on Quanterix

See all news